Arensia Exploratory Medicine S.R.L.
- Address
- lock Available on a paid plan
Neoplasms and Skin and Connective Tissue Diseases
At Arensia Exploratory Medicine S.R.L. in Bucharest, the Clinical Trial Unit is involved in research focused on melanoma, especially adjuvant treatment for patients with resected Stage IIB, IIC, and III melanoma. This work centers on evaluating a new therapy and understanding how it compares with established cancer treatment options.
- Melanoma after complete resection
- Adjuvant treatment for higher-risk skin cancer
- Testing treatment similarity and potential effectiveness in oncology
The site’s cancer research reflects a strong interest in improving care for patients with advanced skin cancer and supporting better treatment choices in Romania.
Diseases of the Liver and Metabolic Disorders
Another key area at this research site is nutritional and metabolic diseases, with studies in advanced liver fibrosis and mild liver cirrhosis. These trials are designed to assess pharmacokinetics and support the development of new approaches for people with chronic liver disease.
- Advanced liver fibrosis
- Mild liver cirrhosis
- Evaluating how a new therapy behaves in the body for hepatic disease
This research highlights the site’s role in studying serious metabolic and liver-related conditions, with a focus on generating evidence that may guide future treatment development.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Arensia Exploratory Medicine S.R.L.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Pharmacokinetic Comparison of FYB206 and Pembrolizumab in Adjuvant Treatment of Stage IIB, IIC, or III Melanoma Post-Resection | Formycon AG | Phase I | Not Recruiting | Oct 2024 | Jul 2026 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.